IT7984134A0 - Furocumarina per la fotochemioterapia della psoriasi e di altre malattie cutanee ad essa sensibili - Google Patents

Furocumarina per la fotochemioterapia della psoriasi e di altre malattie cutanee ad essa sensibili

Info

Publication number
IT7984134A0
IT7984134A0 IT7984134A IT8413479A IT7984134A0 IT 7984134 A0 IT7984134 A0 IT 7984134A0 IT 7984134 A IT7984134 A IT 7984134A IT 8413479 A IT8413479 A IT 8413479A IT 7984134 A0 IT7984134 A0 IT 7984134A0
Authority
IT
Italy
Prior art keywords
furocumarin
photochemotherapy
psoriasis
skin diseases
diseases sensitive
Prior art date
Application number
IT7984134A
Other languages
English (en)
Other versions
IT1166343B (it
Inventor
Dall Acqua Francesco
Baccichetti Francarosa
Guiotto Adriano
Bordin Franco
Pastorini Giovanni
Carlassare Francesco
Rodighiero Giovanni
Rodighiero Paolo
Vedaldi Daniela
Original Assignee
Baccichetti Francarosa
Bordin Franco
Carlassare Francesco
Dall Acqua Francesco
Guiotto Adriano
Pastorini Giovanni
Rodighiero Giovanni
Rodighiero Paolo
Vedaldi Daniela
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baccichetti Francarosa, Bordin Franco, Carlassare Francesco, Dall Acqua Francesco, Guiotto Adriano, Pastorini Giovanni, Rodighiero Giovanni, Rodighiero Paolo, Vedaldi Daniela filed Critical Baccichetti Francarosa
Publication of IT7984134A0 publication Critical patent/IT7984134A0/it
Priority to IT84134/79A priority Critical patent/IT1166343B/it
Priority to GB8026581A priority patent/GB2061726B/en
Priority to BE6/47245A priority patent/BE884813A/fr
Priority to US06/178,292 priority patent/US4312883A/en
Priority to CA000358489A priority patent/CA1162929A/en
Priority to DE3031164A priority patent/DE3031164C2/de
Priority to IE1747/80A priority patent/IE51692B1/en
Priority to FR8018129A priority patent/FR2463616A1/fr
Priority to NLAANVRAGE8004699,A priority patent/NL190448C/xx
Priority to JP55114606A priority patent/JPS5919957B2/ja
Priority to AT100883A priority patent/AT377763B/de
Application granted granted Critical
Publication of IT1166343B publication Critical patent/IT1166343B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/18—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted otherwise than in position 3 or 7
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT84134/79A 1979-08-20 1979-08-20 Furocumarina per la fotochemioterapia della fsoriasi e di altre malattie cutanee ad essa sensibili IT1166343B (it)

Priority Applications (11)

Application Number Priority Date Filing Date Title
IT84134/79A IT1166343B (it) 1979-08-20 1979-08-20 Furocumarina per la fotochemioterapia della fsoriasi e di altre malattie cutanee ad essa sensibili
GB8026581A GB2061726B (en) 1979-08-20 1980-08-14 Furocoumarin for the photochemotherapy of psoriasis
BE6/47245A BE884813A (fr) 1979-08-20 1980-08-14 Furocoumarines pour la photochimiotherapie du psoriasis et d'autres maladies de la peau qui lui sont sensibles
US06/178,292 US4312883A (en) 1979-08-20 1980-08-15 Furocoumarin for the photochemotherapy of psoriasis and related skin diseases
CA000358489A CA1162929A (en) 1979-08-20 1980-08-18 Furocoumarin for the photochemotherapy of psoriasis and other skin diseases sensitive to this treatment and characterized by a cellular hyperproliferation or by lacking of skin pigmentation
DE3031164A DE3031164C2 (de) 1979-08-20 1980-08-18 Angelicine enthaltende Arzneimittel, Angelicine als solche sowie Verfahren zu deren Herstellung
IE1747/80A IE51692B1 (en) 1979-08-20 1980-08-19 Furocoumarin compositions
FR8018129A FR2463616A1 (fr) 1979-08-20 1980-08-19 Furocoumarine pour la photochimiotherapie du psoriasis et d'autres maladies de la peau qui lui sont sensibles
NLAANVRAGE8004699,A NL190448C (nl) 1979-08-20 1980-08-20 Geneesmiddel dat furocoumarinederivaten bevat voor fotochemische therapie.
JP55114606A JPS5919957B2 (ja) 1979-08-20 1980-08-20 フロクマリン化合物およびその塩、およびこれを含有する皮膚病治療剤
AT100883A AT377763B (de) 1979-08-20 1983-03-22 Verfahren zur herstellung neuer furocumarine sowie pharmazeutisch vertraeglicher salze derselben

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT84134/79A IT1166343B (it) 1979-08-20 1979-08-20 Furocumarina per la fotochemioterapia della fsoriasi e di altre malattie cutanee ad essa sensibili

Publications (2)

Publication Number Publication Date
IT7984134A0 true IT7984134A0 (it) 1979-08-20
IT1166343B IT1166343B (it) 1987-04-29

Family

ID=11324549

Family Applications (1)

Application Number Title Priority Date Filing Date
IT84134/79A IT1166343B (it) 1979-08-20 1979-08-20 Furocumarina per la fotochemioterapia della fsoriasi e di altre malattie cutanee ad essa sensibili

Country Status (10)

Country Link
US (1) US4312883A (it)
JP (1) JPS5919957B2 (it)
BE (1) BE884813A (it)
CA (1) CA1162929A (it)
DE (1) DE3031164C2 (it)
FR (1) FR2463616A1 (it)
GB (1) GB2061726B (it)
IE (1) IE51692B1 (it)
IT (1) IT1166343B (it)
NL (1) NL190448C (it)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT390559B (de) * 1982-10-18 1990-05-25 Consiglio Nazionale Ricerche Verwendung von neuen, psoralenfreien 6-methyl-angelicinen bzw. von deren salzen fuer die herstellung von arzneimitteln
IT1165797B (it) * 1982-10-18 1987-04-29 Consiglio Nazionale Ricerche Procedimento di preparazione di alchilangelicine esenti da psoraleni ed alchilangolicine ottenute col procedimento
US5179217A (en) * 1982-10-18 1993-01-12 Francarosa Baccichetti Method of preparing photochemotherapic alkylangelicin compounds
JPS6146451A (ja) * 1984-08-11 1986-03-06 Toshiba Corp スタ−リングエンジン
US4647666A (en) * 1985-04-01 1987-03-03 Iowa State University Research Foundation, Inc. Heterocyclic synthesis via thallation and subsequent palladium-promoted olefination
US4650881A (en) * 1985-04-01 1987-03-17 Iowa State University Research Foundation, Inc. Synthesis of isocoumarins via thallation-olefination of arenes
US5356929A (en) * 1989-01-23 1994-10-18 Lehigh University Reduced and quaternized psoralens as photo-activated therapeutics
WO1990008529A2 (en) * 1989-01-23 1990-08-09 Lehigh University 7-alkoxycoumarins, dihydropsoralens, and benzodipyranones as photo-activated therapeutic agents and inhibitors of epidermal growth factor
US5221608A (en) * 1989-10-26 1993-06-22 Cimino George D Methods for rendering amplified nucleic acid subsequently unamplifiable
US5139940A (en) * 1989-10-26 1992-08-18 Isaacs Stephen T Activation compounds and methods of synthesis of activation compounds
CA2066234C (en) * 1989-10-26 2001-04-03 Stephen T. Isaacs Activation compounds and methods for nucleic acid sterilization
US5503721A (en) * 1991-07-18 1996-04-02 Hri Research, Inc. Method for photoactivation
US5372929A (en) * 1992-01-27 1994-12-13 Cimino; George D. Methods for measuring the inactivation of pathogens
US6433343B1 (en) * 1992-03-02 2002-08-13 Cerus Corporation Device and method for photoactivation
US5556612A (en) * 1994-03-15 1996-09-17 The General Hospital Corporation Methods for phototherapeutic treatment of proliferative skin diseases
US5780446A (en) * 1996-07-09 1998-07-14 Baylor College Of Medicine Formulations of vesicant drugs and methods of use thereof
US6277337B1 (en) 1998-07-21 2001-08-21 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US6258577B1 (en) 1998-07-21 2001-07-10 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using endogenous alloxazine or isoalloxazine photosensitizers
US7498156B2 (en) * 1998-07-21 2009-03-03 Caridianbct Biotechnologies, Llc Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components
US7049110B2 (en) * 1998-07-21 2006-05-23 Gambro, Inc. Inactivation of West Nile virus and malaria using photosensitizers
US20030215784A1 (en) * 1998-07-21 2003-11-20 Dumont Larry Joe Method and apparatus for inactivation of biological contaminants using photosensitizers
US20070099170A1 (en) * 1998-07-21 2007-05-03 Navigant Biotechnologies, Inc. Method for treatment and storage of blood and blood products using endogenous alloxazines and acetate
US7220747B2 (en) 1999-07-20 2007-05-22 Gambro, Inc. Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
US7094378B1 (en) 2000-06-15 2006-08-22 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US6268120B1 (en) 1999-10-19 2001-07-31 Gambro, Inc. Isoalloxazine derivatives to neutralize biological contaminants
US7648699B2 (en) * 2000-06-02 2010-01-19 Caridianbct Biotechnologies, Llc Preventing transfusion related complications in a recipient of a blood transfusion
TW590780B (en) * 2000-06-02 2004-06-11 Gambro Inc Additive solutions containing riboflavin
US7985588B2 (en) * 2000-06-02 2011-07-26 Caridianbct Biotechnologies, Llc Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
US6843961B2 (en) * 2000-06-15 2005-01-18 Gambro, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
ITMI20010685A1 (it) * 2001-03-30 2002-09-30 Biochimici Psn S P A Acido delta-amminolevulinico per uso medico e cosmetico
US6924373B2 (en) * 2003-05-02 2005-08-02 Asiagen Corporation DNA labeling reagents, acridinium-9-carboxamide derivatives and process of preparing DNA labeling compounds
US20080076778A1 (en) * 2006-09-05 2008-03-27 Bipar Sciences, Inc. Methods for designing parp inhibitors and uses thereof
ITVE20070005A1 (it) 2007-01-25 2008-07-26 Associazione Veneta Per La Lotta Alla Talassemia Farmaco per la cura della talassemia, dell'anemia falciforme e di tutte le altre forme di anemia trattabili con questo, metodo di attivazione del farmaco, composizione farmaceutica avente come principio attivo il farmaco e metodo fotochemioterapico u
CN101868255A (zh) * 2007-08-01 2010-10-20 科安比司特生物技术有限责任公司 全血的病原体灭活
WO2009026073A1 (en) * 2007-08-22 2009-02-26 Caridianbct Biotechnologies, Llc Prevention of transfusion related acute lung injury using riboflavin and light
WO2009152210A2 (en) * 2008-06-12 2009-12-17 National Health Research Institutes Coumarin compounds and their use for treating cancer
US20090312406A1 (en) * 2008-06-12 2009-12-17 Hsing-Pang Hsieh Coumarin compounds and their use for treating viral infection

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5298000A (en) * 1976-02-12 1977-08-17 Yoshitomi Pharmaceut Ind Ltd Preparation of novel dihydrofurocoumarin derivatives
JPS5297999A (en) * 1976-02-12 1977-08-17 Yoshitomi Pharmaceut Ind Ltd Dihydrofurocoumarin derivatives

Also Published As

Publication number Publication date
GB2061726A (en) 1981-05-20
DE3031164C2 (de) 1986-08-21
NL8004699A (nl) 1981-02-24
CA1162929A (en) 1984-02-28
IE51692B1 (en) 1987-02-18
NL190448C (nl) 1994-03-01
GB2061726B (en) 1983-10-26
BE884813A (fr) 1980-12-01
JPS5919957B2 (ja) 1984-05-09
FR2463616A1 (fr) 1981-02-27
JPS5630982A (en) 1981-03-28
FR2463616B1 (it) 1984-04-27
IE801747L (en) 1981-02-20
IT1166343B (it) 1987-04-29
US4312883A (en) 1982-01-26
DE3031164A1 (de) 1981-03-12
NL190448B (nl) 1993-10-01

Similar Documents

Publication Publication Date Title
IT7984134A0 (it) Furocumarina per la fotochemioterapia della psoriasi e di altre malattie cutanee ad essa sensibili
BE867137A (nl) Hydroxyalkylfenonen en hun toepassing als fotosensibilisatoren
IT8047806A0 (it) Impiego di benzofuran-2-oni e/o indolin-2-oni come antiossidanti
IT1114950B (it) Composizioni per il trattamento e la terapia di acne
IT1134130B (it) Analoghi di 7-ossabicicloeptano e 7-ossabicicloeptene prostaglandina
IT8025206A0 (it) Derivati di 4-fenil-ftalazine ad azione terapeutica.
IT1096588B (it) Processo per la preparazione di aralchilfenoleteri e di alchilfenoleteri
IT1099251B (it) Capi di vestiario e procedimento per la loro fabbricazione
ES256776Y (es) Dosimetro personal
IT1133968B (it) Procedimento per la lavorazione della cartaccia ed impianto per eseguire il procedimento
IT8048536A0 (it) Semilavorati laminati spianati di polisolfone e procedimento per ottenerli
NO150482C (no) Mellomprodukter for fremstilling av terapeutisk aktive antrakinon-derivater
IT7850906A0 (it) Loro produzione e applicazione cicloamminali e procedimento per la
IT7852488A0 (it) Procedimento per la produzione di alcoli benzilici
TR20880A (tr) Akrilonitrilin aritilmasi
ES495065A0 (es) Procedimiento para mejorar la eficacia de catalizadores con soporte de plata
IT1132527B (it) Procedimento e dispositivo per la produzione continua di poliuretani
IT1098382B (it) Struttura di emodializzatore
IT1089324B (it) Procedimento per la produzione di acetone e butanolo
IT1192563B (it) Composizione per il trattamento di malattie allergiche
IT1141631B (it) Procedimento per il rinverdimento di pelli da pelliccia
IT1099048B (it) Procedimento per la preparazione di maltosio-fosforilasi o/e di bet-fosfoglucosio-mutasi e loro impiego
IT1109257B (it) Procedimento per la produzione di idantoine e loro applicazione
AR223697A1 (es) Derivado de o-alquil-s-(6-alquil-pirimidina-2-il-metil)-fosforotioato y procedimiento para obtenerlo
IT1101261B (it) Derivato tiolico per il trattamento della cellulite

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19940830